Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised

Baldanti, 1995, Four dually resistant strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir- and foscarnet-specific resistance, respectively, Scand J Infect Dis Suppl, 99, 103 Baldanti, 1995, A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate, J Virol, 69, 796, 10.1128/JVI.69.2.796-800.1995 Baldanti, 1996, Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS, J Virol, 70, 1390, 10.1128/JVI.70.3.1390-1395.1996 Baldanti F, Simoncini L, Talarico CL, Sarasini A, Biron KK, Gerna G. Emergence of a ganciclovir-resistant human cytomegalovirus strain with a new UL97 mutation (Gly598⇒Ser) in an AIDS patient. AIDS 1998a; 12: 816–8. Baldanti, 1998, The Cys607⇒Tyr change in the UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patients, Antimicrob Agents Chemother, 42, 444, 10.1128/AAC.42.2.444 Baldanti F, Zavattoni M, Simoncini L, et al. Ganciclovir (GCV) resistance following multiple courses of intravenous and oral GCV in an heart transplant recipient infected by multiple HCMV strains. Transplantation 1998c (in press). Bitsch, 1993, The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection, Transplantation, 56, 108, 10.1097/00007890-199307000-00020 Boeckh, 1992, Cytomegalovirus antigen detection in peripheral blood leukocytes after allogenic marrow transplantation, Blood, 80, 1358, 10.1182/blood.V80.5.1358.1358 Boeckh, 1994, Factors influencing detection of quantitative cytomegalovirus antigenemia, J Clin Microbiol, 32, 832, 10.1128/JCM.32.3.832-834.1994 Boivin, 1995, Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease, J Infect Dis, 173, 523, 10.1093/infdis/173.3.523 Boivin, 1997, A case of ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with AIDS: longitudinal molecular analysis of the CMV viral load and viral mutations in blood compartments, AIDS, 11, 867, 10.1097/00002030-199707000-00005 Boland, 1990, Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection, J Clin Microbiol, 28, 2069, 10.1128/JCM.28.9.2069-2075.1990 Cinque, 1995, Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid, J Infect Dis, 171, 1603, 10.1093/infdis/171.6.1603 Delgado, 1992, Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients, J Clin Microbiol, 30, 1876, 10.1128/JCM.30.7.1876-1878.1992 Erice, 1987, Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts, J Am Med Assoc, 257, 3082, 10.1001/jama.257.22.3082 Fanning, 1990, Foscarnet therapy of cytomegalovirus retinitis in AIDS, J AIDS, 3, 472 Gerna, 1990, Human cytomegalovirus viraemia in HIV-1-seropositive patients at various stages of infection, AIDS, 4, 1027, 10.1097/00002030-199010000-00014 Gerna, 1990, Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins, J Clin Microbiol, 28, 2681, 10.1128/JCM.28.12.2681-2688.1990 Gerna, 1991, Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia, Mol Cell Probes, 5, 365, 10.1016/S0890-8508(06)80008-3 Gerna, 1991, Monitoring of human cytomegalovirus infections and ganciclovir treatment in transplant recipients by determination of viremia antigenemia and DNAemia, J Infect Dis, 164, 488, 10.1093/infdis/164.3.488 Gerna, 1992, Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate–early antigen plaque assay, Antivir Res, 19, 333, 10.1016/0166-3542(92)90014-V Gerna, 1992, Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia, J Clin Microbiol, 30, 1232, 10.1128/JCM.30.5.1232-1237.1992 Gerna, 1993, Correlation of quantitative human cytomegalovirus pp65-, p72- and p150-antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromised patients, Clin Diagn Virol, 1, 47, 10.1016/0928-0197(93)90033-2 Gerna, 1994, Effect of foscarnet treatment on quantitation of human cytomegalovirus (HCMV) DNA in blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis, Antimicrob Agents Chemother, 38, 38, 10.1128/AAC.38.1.38 Gerna, 1994, Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients, J Clin Microbiol, 32, 2709, 10.1128/JCM.32.11.2709-2717.1994 Gerna, 1995, Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients, Br J Haematol, 91, 674, 10.1111/j.1365-2141.1995.tb05368.x Gerna, 1995, Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples, J Clin Microbiol, 33, 738, 10.1128/JCM.33.3.738-741.1995 Gerna, 1997, Quantitative systemic and local evaluation of the antiviral effect of ganciclovir and foscarnet induction treatment on human cytomegalovirus gastrointestinal disease of patients with AIDS, Antivir Res, 34, 39, 10.1016/S0166-3542(96)01020-0 Gerna G, Zavattoni M, Baldanti F, Sarasini A, Chezzi L, Grossi P, Revello MG. Human cytomegalovirus (HCMV) leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart–lung transplant recipients with primary HCMV infection. Transplantation 1998; 65: 1378–85. Grefte, 1992, The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection, J Gen Virol, 3, 2923, 10.1099/0022-1317-73-11-2923 Grossi, 1995, Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients, Transplantation, 59, 847, 10.1097/00007890-199503270-00008 Ho, 1975, The transplanted kidney as a source of cytomegalovirus infection, New Engl J Med, 293, 1109, 10.1056/NEJM197511272932201 Jacobson, 1988, Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS): clinical findings, diagnosis and treatment, Ann Intern Med, 108, 585, 10.7326/0003-4819-108-4-585 Jacobson, 1988, Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immunedeficiency syndrome: prevalence, natural history, and response to ganciclovir therapy, Q J Med, 67, 473 Landry, 1993, Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease, J Clin Microbiol, 31, 2851, 10.1128/JCM.31.11.2851-2856.1993 Locatelli, 1994, Human cytomegalovirus (HCMV) infection in paediatric patients given allogenic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients’ outcome, Br J Haematol, 88, 64, 10.1111/j.1365-2141.1994.tb04978.x Mazzulli, 1993, Cytomegalovirus antigenemia: correlations in transplant recipients and in persons with AIDS, J Clin Microbiol, 31, 2824, 10.1128/JCM.31.10.2824-2827.1993 Myers, 1986, Risk factors for cytomegalovirus infection after human marrow transplantation, J Infect Dis, 153, 478, 10.1093/infdis/153.3.478 Reichert, 1983, Authopsy pathology in the acquired immune deficiency syndrome, Am J Pathol, 12, 357 Revello, 1992, Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients, J Gen Virol, 73, 437, 10.1099/0022-1317-73-2-437 Revello, 1994, Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients, J Infect Dis, 170, 1275, 10.1093/infdis/170.5.1275 Saltzman, 1988, Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interaction in viremia, J Clin Invest, 81, 75, 10.1172/JCI113313 Sarasini, 1995, Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients, J Med Virol, 47, 237, 10.1002/jmv.1890470309 Spector, 1992, Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification, J Clin Microbiol, 30, 2359, 10.1128/JCM.30.9.2359-2365.1992 The, 1995, The cytomegalovirus antigenemia assay: a plea for standardization, Scand J Infect Dis Suppl, 99, 25 Van der Berg, 1989, Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation: a report of 130 consecutive patients, Transplantation, 48, 991, 10.1097/00007890-198912000-00019 Van der Berg, 1991, Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation, J Infect Dis, 164, 265, 10.1093/infdis/164.2.265 Van der Bij, 1988, Comparison between viremia and antigenemia for detection of cytomegalovirus in blood, J Clin Microbiol, 26, 2531, 10.1128/JCM.26.12.2531-2535.1988 Van der Bij, 1988, Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes, J Med Virol, 25, 179, 10.1002/jmv.1890250208